annual ROE:
-211.71%-18.48%(-9.56%)Summary
- As of today (September 16, 2025), RARE annual return on equity is -211.71%, with the most recent change of -18.48% (-9.56%) on December 31, 2024.
- During the last 3 years, RARE annual ROE has fallen by -167.99% (-384.24%).
- RARE annual ROE is now -925.73% below its all-time high of -20.64%, reached on December 31, 2020.
Performance
RARE ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-196.21%+8.85%(+4.32%)Summary
- As of today (September 16, 2025), RARE quarterly return on equity is -196.21%, with the most recent change of +8.85% (+4.32%) on June 30, 2025.
- Over the past year, RARE quarterly ROE has increased by +93.79% (+32.34%).
- RARE quarterly ROE is now -1266.36% below its all-time high of -14.36%, reached on December 31, 2012.
Performance
RARE quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
RARE ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.6% | +32.3% |
| 3 y3 years | -384.2% | -233.8% |
| 5 y5 years | -231.9% | -357.8% |
RARE ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -384.2% | at low | -233.8% | +49.0% |
| 5 y | 5-year | -925.7% | at low | -705.5% | +49.0% |
| alltime | all time | -925.7% | at low | -1266.4% | +49.0% |
RARE ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -196.21%(-4.3%) |
| Mar 2025 | - | -205.06%(+5.5%) |
| Dec 2024 | -211.71%(+9.6%) | -194.36%(-14.2%) |
| Sep 2024 | - | -226.56%(-21.9%) |
| Jun 2024 | - | -290.00%(-24.6%) |
| Mar 2024 | - | -384.83%(+28.0%) |
| Dec 2023 | -193.23%(+74.1%) | -300.57%(+13.8%) |
| Sep 2023 | - | -264.14%(+35.5%) |
| Jun 2023 | - | -194.91%(+36.4%) |
| Mar 2023 | - | -142.88%(+30.0%) |
| Dec 2022 | -110.96%(+153.8%) | -109.90%(+23.2%) |
| Sep 2022 | - | -89.23%(+51.8%) |
| Jun 2022 | - | -58.79%(+17.0%) |
| Mar 2022 | - | -50.24%(+11.5%) |
| Dec 2021 | -43.72%(+111.8%) | -45.07%(+21.2%) |
| Sep 2021 | - | -37.19%(-3.9%) |
| Jun 2021 | - | -38.68%(+58.8%) |
| Mar 2021 | - | -24.36%(-1.3%) |
| Dec 2020 | -20.64%(-67.6%) | -24.68%(-35.5%) |
| Sep 2020 | - | -38.24%(-10.8%) |
| Jun 2020 | - | -42.86%(-25.4%) |
| Mar 2020 | - | -57.48%(+5.5%) |
| Dec 2019 | -63.79%(+60.2%) | -54.47%(+1.7%) |
| Sep 2019 | - | -53.54%(+6.3%) |
| Jun 2019 | - | -50.39%(+11.3%) |
| Mar 2019 | - | -45.26%(+41.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | -39.83%(-43.5%) | -32.05%(-5.0%) |
| Sep 2018 | - | -33.73%(-4.1%) |
| Jun 2018 | - | -35.19%(-17.4%) |
| Mar 2018 | - | -42.58%(-39.7%) |
| Dec 2017 | -70.48%(+44.0%) | -70.56%(+7.1%) |
| Sep 2017 | - | -65.89%(+8.9%) |
| Jun 2017 | - | -60.52%(+8.9%) |
| Mar 2017 | - | -55.57%(+8.2%) |
| Dec 2016 | -48.93%(+20.3%) | -51.34%(+11.6%) |
| Sep 2016 | - | -46.01%(+6.4%) |
| Jun 2016 | - | -43.23%(+10.3%) |
| Mar 2016 | - | -39.19%(+5.1%) |
| Dec 2015 | -40.67%(-20.1%) | -37.28%(+12.8%) |
| Sep 2015 | - | -33.04%(-5.5%) |
| Jun 2015 | - | -34.96%(+8.1%) |
| Mar 2015 | - | -32.35%(-18.5%) |
| Dec 2014 | -50.88%(-2.5%) | -39.70%(-8.1%) |
| Sep 2014 | - | -43.20%(-15.6%) |
| Jun 2014 | - | -51.18%(+18.1%) |
| Mar 2014 | - | -43.35%(-6.3%) |
| Dec 2013 | -52.17%(+26.7%) | -46.26%(+26.8%) |
| Sep 2013 | - | -36.49%(+48.8%) |
| Jun 2013 | - | -24.53%(+9.8%) |
| Mar 2013 | - | -22.35%(+55.6%) |
| Dec 2012 | -41.19%(-41.3%) | -14.36% |
| Dec 2011 | -70.15% | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual return on equity?
- What is the all time high annual ROE for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual ROE year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly return on equity?
- What is the all time high quarterly ROE for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly ROE year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual return on equity?
The current annual ROE of RARE is -211.71%
What is the all time high annual ROE for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual return on equity is -20.64%
What is Ultragenyx Pharmaceutical Inc. annual ROE year-on-year change?
Over the past year, RARE annual return on equity has changed by -18.48% (-9.56%)
What is Ultragenyx Pharmaceutical Inc. quarterly return on equity?
The current quarterly ROE of RARE is -196.21%
What is the all time high quarterly ROE for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly return on equity is -14.36%
What is Ultragenyx Pharmaceutical Inc. quarterly ROE year-on-year change?
Over the past year, RARE quarterly return on equity has changed by +93.79% (+32.34%)